Please assess the completion status of the following clinical trial:

Trial Title: Improving Asthma Control in the Real World: A Systematic Approach to Improving Dulera Adherence

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Physician diagnosis of asthma of moderate severity~2. Subjects ≥ 18 years of age~3. Currently receiving an inhaled corticosteroid medication and being prescribed Dulera 100/5 as part of standard of care based upon asthma severity and dosing guidelines~4. Asthma Control Questionnaire (ACQ) result \> 1.0 at entry~5. Demonstration of correct inhalation technique for use of meter-dosed inhalers (MDIs)~6. History of reversible airway obstruction documented by treating physician Exclusion Criteria: intermittent asthma; emphysema, chronic obstructive pulmonary disease; chronic bronchitis; cystic fibrosis; medication that may have a drug interaction with Dulera~Exclusion Criteria~1. Intermittent asthma (asthma exacerbations or symptoms \< 3 days/week)~2. Diagnosis of emphysema in prior year~3. Diagnosis at any time of: chronic obstructive pulmonary disease (COPD), chronic bronchitis, cystic fibrosis, bronchiectasis, Churg Strauss, Wegener's, sarcoidosis, pulmonary hypertension or lung cancer~4. On any medication documented to have a drug interaction with Dulera

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Dulera adherence monitoring (Type: EXPERIMENTAL): Adherence Monitoring Dulera; Identification of adherence barrier(s); Motivational Interviewing Adherence Strategies to promote adherence
- Dulera Standard of Asthma Care (Type: ACTIVE_COMPARATOR): Dulera standard of asthma care

Based on this trial design, predict the completion outcome and termination type (if applicable).